NA
BIIB icon

Navellier & Associates’s Biogen BIIB Stock Holding History

Navellier & Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$397K Hold
2,164
– – 0.04% 245
2025
Q4 		$381K Hold
2,164
– – 0.04% 253
2025
Q3 		$303K Hold
2,164
– – 0.03% 315
2025
Q2 		$272K Hold
2,164
– – 0.03% 272
2025
Q1 		$264K Hold
2,164
– – 0.04% 270
2024
Q4 		$331K Hold
2,164
– – 0.04% 269
2024
Q3 		$419K Hold
2,164
– – 0.06% 242
2024
Q2 		$502K Hold
2,164
– – 0.06% 242
2024
Q1 		$467K Hold
2,164
– – 0.06% 251
2023
Q4 		$560K Hold
2,164
– – 0.08% 207
2023
Q3 		$556K Buy
+2,164
New +$579K 0.1% 195
2016
Q1 		– Sell
-3,146
Closed -$964K – 263
2015
Q4 		$964K Sell
3,146
-1,600
-34% -$460K 0.11% 88
2015
Q3 		$1.39M Sell
4,746
-71,087
-94% -$23.5M 0.14% 70
2015
Q2 		$30.6M Buy
75,833
+1,953
+3% +$784K 2.69% 10
2015
Q1 		$31.2M Sell
73,880
-92,993
-56% -$36.7M 2.83% 12
2014
Q4 		$56.6M Sell
166,873
-8,596
-5% -$2.78M 2.83% 10
2014
Q3 		$58M Sell
175,469
-22,304
-11% -$7.35M 2.92% 10
2014
Q2 		$62.4M Sell
197,773
-15,545
-7% -$4.68M 2.82% 8
2014
Q1 		$65.2M Sell
213,318
-3,282
-2% -$1.04M 3.04% 8
2013
Q4 		$60.6M Sell
216,600
-108,796
-33% -$28.1M 2.73% 9
2013
Q3 		$78.3M Sell
325,396
-9,044
-3% -$2.02M 2.31% 2
2013
Q2 		$72M Buy
+334,440
New +$71.5M 3.43% 3

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Navellier & Associates's BIIB Position: Q1 2026 in Review

Navellier & Associates held its Biogen (BIIB) position steady in Q1 2026 at 2,164 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #245.

Navellier & Associates first reported a position in BIIB in Q2 2013 and has held it in 22 quarters since. The position peaked at $78.3M in Q3 2013. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Navellier & Associates held 2,164 shares of Biogen worth $397K as of Q1 2026.
  • Navellier & Associates left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.04% of Navellier & Associates's portfolio in Q1 2026, its #245 holding.
  • Navellier & Associates first reported a position in Biogen in Q2 2013 and has held it in 22 quarters since.
  • Navellier & Associates's Biogen position peaked at $78.3M in Q3 2013.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.